Gómez-Pérez FJ - Search Results

1

A Novel, Likely Pathogenic MAX Germline Variant in a Patient With Unilateral Pheochromocytoma.

Lam-Chung CE, Rodríguez LL, Vázquez JA, Chávarri-Guerra Y, Arízaga-Ramírez R, Antonio OF, De Anda González J, López-Hernández MA, Weitzel JN, Castillo D, Gómez-Pérez FJ, Cuevas-Ramos D. Lam-Chung CE, et al. J Endocr Soc. 2021 Jun 3;5(8):bvab085. doi: 10.1210/jendso/bvab085. eCollection 2021 Aug 1. J Endocr Soc. 2021. PMID: 34169220 Free PMC article.

2

The role of fibroblast growth factor 21 (FGF21) on energy balance, glucose and lipid metabolism.

Cuevas-Ramos D, Almeda-Valdes P, Aguilar-Salinas CA, Cuevas-Ramos G, Cuevas-Sosa AA, Gomez-Perez FJ. Cuevas-Ramos D, et al. Curr Diabetes Rev. 2009 Nov;5(4):216-20. doi: 10.2174/157339909789804396. Curr Diabetes Rev. 2009. PMID: 19531026 Review.

3

UKPDS Risk Engine, decode and diabetes PHD models for the estimation of cardiovascular risk in patients with diabetes.

Almeda-Valdes P, Cuevas-Ramos D, Mehta R, Gomez-Perez FJ, Aguilar-Salinas CA. Almeda-Valdes P, et al. Curr Diabetes Rev. 2010 Jan;6(1):1-8. doi: 10.2174/157339910790442646. Curr Diabetes Rev. 2010. PMID: 20034373 Review.

4

Beta-cell adenomas without hyperinsulinemia with use of highly specific insulin radioimmunoassays: case report and review of literature.

Gómez-Pérez FJ, Cuevas-Ramos D, Valdés PA, Aguilar-Salinas CA, Mehta R, Rull JA. Gómez-Pérez FJ, et al. Endocr Pract. 2010 Jul-Aug;16(4):660-3. doi: 10.4158/EP10016.CR. Endocr Pract. 2010. PMID: 20439243 Review.

5

Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.

Cuevas-Ramos D, Almeda-Valdes P, Gómez-Pérez FJ, Meza-Arana CE, Cruz-Bautista I, Arellano-Campos O, Navarrete-López M, Aguilar-Salinas CA. Cuevas-Ramos D, et al. Eur J Endocrinol. 2010 Sep;163(3):469-77. doi: 10.1530/EJE-10-0454. Epub 2010 Jun 21. Eur J Endocrinol. 2010. PMID: 20566587

6

Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance.

Almeda-Valdes P, Cuevas-Ramos D, Mehta R, Gomez-Perez FJ, Cruz-Bautista I, Arellano-Campos O, Navarrete-Lopez M, Aguilar-Salinas CA. Almeda-Valdes P, et al. Cardiovasc Diabetol. 2010 Jun 23;9:26. doi: 10.1186/1475-2840-9-26. Cardiovasc Diabetol. 2010. PMID: 20573249 Free PMC article.

7

HbA1c for the diagnosis of diabetes mellitus in a developing country. A position article.

Gomez-Perez FJ, Aguilar-Salinas CA, Almeda-Valdes P, Cuevas-Ramos D, Lerman Garber I, Rull JA. Gomez-Perez FJ, et al. Arch Med Res. 2010 May;41(4):302-8. doi: 10.1016/j.arcmed.2010.05.007. Arch Med Res. 2010. PMID: 20637376

8

Treatment of metabolic syndrome slows progression of diabetic nephropathy.

Duran-Perez EG, Almeda-Valdes P, Cuevas-Ramos D, Campos-Barrera E, Muñoz-Hernandez L, Gomez-Perez FJ. Duran-Perez EG, et al. Metab Syndr Relat Disord. 2011 Dec;9(6):483-9. doi: 10.1089/met.2011.0056. Epub 2011 Aug 29. Metab Syndr Relat Disord. 2011. PMID: 21875335

9

Sensorineural hearing loss--a common finding in early-onset type 2 diabetes mellitus.

Lerman-Garber I, Cuevas-Ramos D, Valdés S, Enríquez L, Lobato M, Osornio M, Escobedo AR, Pascual-Ramos V, Mehta R, Ramírez-Anguiano J, Gómez-Pérez FJ. Lerman-Garber I, et al. Endocr Pract. 2012 Jul-Aug;18(4):549-57. doi: 10.4158/EP11389.OR. Endocr Pract. 2012. PMID: 22440999

10

Exercise increases serum fibroblast growth factor 21 (FGF21) levels.

Cuevas-Ramos D, Almeda-Valdés P, Meza-Arana CE, Brito-Córdova G, Gómez-Pérez FJ, Mehta R, Oseguera-Moguel J, Aguilar-Salinas CA. Cuevas-Ramos D, et al. PLoS One. 2012;7(5):e38022. doi: 10.1371/journal.pone.0038022. Epub 2012 May 31. PLoS One. 2012. PMID: 22701542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page